ELI LILLY AND COMPANY Payments to Acquire Short-term Investments
ELI LILLY AND COMPANY (LLY) reported Payments to Acquire Short-term Investments of $98.50 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-19.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2025-02-19
- ELI LILLY AND COMPANY payments to acquire short-term investments for the quarter ending 2024-12-31 was $29.90M, a 57.37% increase year-over-year.
- ELI LILLY AND COMPANY payments to acquire short-term investments for the quarter ending 2024-09-30 was $19.80M, a 2.06% increase year-over-year.
- ELI LILLY AND COMPANY payments to acquire short-term investments for the quarter ending 2024-06-30 was $24.40M, a 33.70% decline year-over-year.
- ELI LILLY AND COMPANY payments to acquire short-term investments for the quarter ending 2024-03-31 was $24.40M, a 6.09% increase year-over-year.
- ELI LILLY AND COMPANY payments to acquire short-term investments for fiscal 2024 was $98.50M, a 0.31% increase from fiscal 2023.
- ELI LILLY AND COMPANY payments to acquire short-term investments for fiscal 2023 was $98.20M, a 8.57% decline from fiscal 2022.
- ELI LILLY AND COMPANY payments to acquire short-term investments for fiscal 2022 was $107.40M, a 28.62% increase from fiscal 2021.
- ELI LILLY AND COMPANY payments to acquire short-term investments for fiscal 2021 was $83.50M, a 632.46% increase from fiscal 2020.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2024-12-31 | $29.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $49.70M derived: sum of 2 quarters · filed 2025-02-19 | $74.10M derived: sum of 3 quarters · filed 2025-02-19 | $98.50M 10-K · filed 2025-02-19 |
| 2024-09-30 | $19.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $44.20M derived: sum of 2 quarters · filed 2024-10-30 | $68.60M 10-Q · filed 2024-10-30 | $87.60M derived: sum of 4 quarters · filed 2025-02-19 |
| 2024-06-30 | $24.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $48.80M 10-Q · filed 2024-08-08 | $67.80M derived: sum of 3 quarters · filed 2025-02-19 | $87.20M derived: sum of 4 quarters · filed 2025-02-19 |
| 2024-03-31 | $24.40M 10-Q · filed 2024-04-30 | $43.40M derived: sum of 2 quarters · filed 2025-02-19 | $62.80M derived: sum of 3 quarters · filed 2025-02-19 | $99.60M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $38.40M derived: sum of 2 quarters · filed 2025-02-19 | $75.20M derived: sum of 3 quarters · filed 2025-02-19 | $98.20M 10-K · filed 2025-02-19 |
| 2023-09-30 | $19.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $56.20M derived: sum of 2 quarters · filed 2024-10-30 | $79.20M 10-Q · filed 2024-10-30 | $121.60M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-06-30 | $36.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $59.80M 10-Q · filed 2024-08-08 | $102.20M derived: sum of 3 quarters · filed 2025-02-19 | $134.30M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-03-31 | $23.00M 10-Q · filed 2024-04-30 | $65.40M derived: sum of 2 quarters · filed 2025-02-19 | $97.50M derived: sum of 3 quarters · filed 2025-02-19 | $115.80M derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | $42.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $74.50M derived: sum of 2 quarters · filed 2025-02-19 | $92.80M derived: sum of 3 quarters · filed 2025-02-19 | $107.40M 10-K · filed 2025-02-19 |
| 2022-09-30 | $32.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $50.40M derived: sum of 2 quarters · filed 2023-11-02 | $65.00M 10-Q · filed 2023-11-02 | $120.60M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $18.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $32.90M 10-Q · filed 2023-08-08 | $88.50M derived: sum of 3 quarters · filed 2024-02-21 | $89.80M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $14.60M 10-Q · filed 2023-04-27 | $70.20M derived: sum of 2 quarters · filed 2024-02-21 | $71.50M derived: sum of 3 quarters · filed 2024-02-21 | $78.70M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $55.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $56.90M derived: sum of 2 quarters · filed 2024-02-21 | $64.10M derived: sum of 3 quarters · filed 2024-02-21 | $83.50M 10-K · filed 2024-02-21 |
| 2021-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $8.50M derived: sum of 2 quarters · filed 2022-11-01 | $27.90M 10-Q · filed 2022-11-01 | $27.90M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $7.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $26.60M 10-Q · filed 2022-08-04 | $26.60M derived: sum of 3 quarters · filed 2023-02-22 | $38.00M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $19.40M 10-Q · filed 2022-04-29 | $19.40M derived: sum of 2 quarters · filed 2023-02-22 | $30.80M derived: sum of 3 quarters · filed 2023-02-22 | $30.80M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $11.40M derived: sum of 2 quarters · filed 2023-02-22 | $11.40M derived: sum of 3 quarters · filed 2023-02-22 | $11.40M 10-K · filed 2023-02-22 |
| 2020-09-30 | $11.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $11.40M derived: sum of 2 quarters · filed 2021-10-27 | $11.40M 10-Q · filed 2021-10-27 | $20.00M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $0.00 10-Q · filed 2021-08-03 | $8.60M derived: sum of 3 quarters · filed 2022-02-23 | $8.60M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $0.00 10-Q · filed 2021-04-30 | $8.60M derived: sum of 2 quarters · filed 2022-02-23 | $8.60M derived: sum of 3 quarters · filed 2022-02-23 | $9.00M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $8.60M derived: sum of 2 quarters · filed 2022-02-23 | $9.00M derived: sum of 3 quarters · filed 2022-02-23 | $42.70M 10-K · filed 2022-02-23 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $400.00K derived: sum of 2 quarters · filed 2020-10-28 | $34.10M 10-Q · filed 2020-10-28 | $34.10M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $34.10M 10-Q · filed 2020-07-31 | $34.10M derived: sum of 3 quarters · filed 2021-02-17 | $34.10M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-31 | $33.70M 10-Q · filed 2020-05-01 | $33.70M derived: sum of 2 quarters · filed 2021-02-17 | $33.70M derived: sum of 3 quarters · filed 2021-02-17 | $33.70M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $0.00 derived: sum of 2 quarters · filed 2021-02-17 | $0.00 derived: sum of 3 quarters · filed 2021-02-17 | $112.20M 10-K · filed 2021-02-17 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $0.00 derived: sum of 2 quarters · filed 2019-10-25 | $112.20M 10-Q · filed 2019-10-25 | $528.10M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $112.20M 10-Q · filed 2019-08-02 | $528.10M derived: sum of 3 quarters · filed 2020-02-19 | $1.62B derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $112.20M 10-Q · filed 2019-05-02 | $528.10M derived: sum of 2 quarters · filed 2020-02-19 | $1.62B derived: sum of 3 quarters · filed 2020-02-19 | $3.21B derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $415.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $1.51B derived: sum of 2 quarters · filed 2020-02-19 | $3.10B derived: sum of 3 quarters · filed 2020-02-19 | $3.39B 10-K · filed 2020-02-19 |
| 2017-09-30 | $1.09B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $2.68B derived: sum of 2 quarters · filed 2018-11-06 | $2.97B 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $1.59B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25 | $1.88B 10-Q · filed 2018-07-25 | ||
| 2017-03-31 | $289.40M 10-Q · filed 2018-04-27 | |||
| 2016-09-30 | $160.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $327.30M derived: sum of 2 quarters · filed 2017-10-27 | $425.70M 10-Q · filed 2017-10-27 | |
| 2016-06-30 | $166.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $265.30M 10-Q · filed 2017-07-28 | ||
| 2016-03-31 | $98.40M 10-Q · filed 2017-05-01 | |||
| 2015-09-30 | $175.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $598.40M derived: sum of 2 quarters · filed 2016-10-28 | $764.20M 10-Q · filed 2016-10-28 | |
| 2015-06-30 | $422.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $588.50M 10-Q · filed 2016-07-28 | ||
| 2015-03-31 | $165.80M 10-Q · filed 2016-04-29 | |||
| 2014-09-30 | $597.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $999.00M derived: sum of 2 quarters · filed 2015-10-30 | $1.40B 10-Q · filed 2015-10-30 | |
| 2014-06-30 | $401.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $804.50M 10-Q · filed 2015-07-30 | ||
| 2014-03-31 | $402.80M 10-Q · filed 2015-04-30 | |||
| 2013-09-30 | $263.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $465.50M derived: sum of 2 quarters · filed 2014-10-29 | $778.60M 10-Q · filed 2014-10-29 | |
| 2013-06-30 | $202.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-28 | $515.60M 10-Q · filed 2014-07-28 | ||
| 2013-03-31 | $313.10M 10-Q · filed 2014-04-28 | |||
| 2012-09-30 | $1.09B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $1.26B derived: sum of 2 quarters · filed 2013-10-30 | $1.87B 10-Q · filed 2013-10-30 | |
| 2012-06-30 | $163.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26 | $776.60M 10-Q · filed 2013-07-26 | ||
| 2012-03-31 | $612.90M 10-Q · filed 2013-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |